As of 2025-07-02, the Intrinsic Value of XBiotech Inc (XBIT) is -6.46 USD. This XBIT valuation is based on the model Peter Lynch Fair Value. With the current market price of 3.17 USD, the upside of XBiotech Inc is -303.86%.
Based on its market price of 3.17 USD and our intrinsic valuation, XBiotech Inc (XBIT) is overvalued by 303.86%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -6.46 - -6.46 | -6.46 | -303.86% |
| P/E | (12.95) - (23.52) | (16.87) | -632.1% |
| DDM - Stable | (11.41) - (33.71) | (22.56) | -811.6% |
| DDM - Multi | (10.11) - (23.51) | (14.17) | -547.0% |
| Market Cap (mil) | 96.65 |
| Beta | 1.10 |
| Outstanding shares (mil) | 30.49 |
| Enterprise Value (mil) | -59.24 |
| Market risk premium | 4.60% |
| Cost of Equity | 9.69% |
| Cost of Debt | 5.00% |
| WACC | 9.17% |